Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results
SEATTLE, April 19, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better...
Month: April 2021
Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene Therapy Data in Blood, the Journal of the American Society of Hematology
CB 2679d-GT significantly outperformed the R338L-Padua transgene after treatment with AAV-gene therapy in hemophilia B miceSOUTH SAN FRANCISCO, Calif., April 19,...
Daré Bioscience Appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors
SAN DIEGO, April 19, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment
MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...
OVID Provides Update on OV101 Program and the Prioritization of its Resources
Completed Soticlestat Agreement with Takeda Provides Significant Resources to Advance and Enrich OVID’s Pipeline, Including OV882 for Angelman Syndrome Company...
Rezolute Announces $30 Million Debt Financing Agreement with SLR Capital Partners
REDWOOD CITY, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (Nasdaq: RZLT), a clinical stage...
Immutep Quarterly Activities Report
Highlights Safely dosed the last HNSCC patient for Stage 2 of Part C of the TACTI-002 Phase II study (also...
University of Miami Health System and One Medical Announce Affiliation Focused on Seamless Coordinated Care
One Medical plans to bring its technology-powered primary care model to FloridaMIAMI and SAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE)...
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
2021: Executing on Opportunities and Preparing for the FutureFRAMINGHAM, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:...
CERiS Offers First Prepayment Dual Reviews For Payment Integrity Programs
Itemized Bill Review and DRG Validation Are Performed by a Division of a Publicly Traded Company, Independent from Ongoing Market...
Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits
New global distribution partner McWilliams Collective secures test kit order from European clientToronto, Ontario--(Newsfile Corp. - April 19, 2021) -...
Embark Delta Inc. Completes Additional Shipment to Province of Ontario
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
Embark Delta Inc. Completes First Shipment to Province of Saskatchewan
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
LivaNova Achieves Clinical Milestone in Heart Failure Program
300th patient randomized in ANTHEM-HFrEF pivotal study LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced...
AgNovos Healthcare Receives Investigational Device Exemption (IDE) for Breakthrough Spine Device
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, a developer of medical technology products leveraging regenerative medicine to treat the local effects of bone...
CareLineLive secures £1.2 million funding to support digitalisation and innovation within the homecare sector
Led by Haatch Ventures, the investment will support CareLineLive’s international expansion and grow headcount London, UK; 19th April 2021: CareLineLive,...
Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
EVOTEC GRANTS KAZIA THERAPEUTICS AN EXCLUSIVE WORLDWIDE LICENSE FOR DEVELOPMENT AND COMMERCIALISATION OF ONCOLOGY ASSET EVT801 KAZIA INTENDS TO INITIATE...
Relief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp.
GENEVA, SWITZERLAND / ACCESSWIRE / April 19, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), commented today...
VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021
Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy Effect...
Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.
VANCOUVER, BC / ACCESSWIRE / April 17, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") a biotechnology research...